Literature DB >> 8035282

Fundoplication in 160 children under 2 years of age.

N L Kazerooni1, J VanCamp, R B Hirschl, R A Drongowski, A G Coran.   

Abstract

The natural history of fundoplication in young children with gastroesophageal reflux (GER) had not been analyzed previously. The authors reviewed the charts of 160 children who underwent gastric fundoplication (GF) before the age of 2 years (mean age [+/- SD], 9 +/- 7 months; range, 1 week to 2 years), from 1974 to 1992. Reflux was documented by upper gastrointestinal series in 124 patients, by 24-hour pH probe monitor in 98 patients, and by both in 68 patients. Clinical indications for GF included failure to thrive (FTT) in 68%, emesis (Ems) in 58%, and aspiration pneumonia (Asp) in 53%. Neurological impairment (NI) was present in 47% of all patients, and 13% had esophageal atresia (EA). The type of GF used was a Nissen fundoplication in 79% and an anterior fundoplication (AF) in 21%. Of the 160 patients, 24 (15%) died of unrelated causes. Of the remaining 136, follow-up of at least 2 years was obtained for 96 (mean follow-up period, 5.3 +/- 3.0 years; range, 2 to 15 years). Clinical resolution of symptoms/findings after GF occurred in 87% of children with FTT, 92% with Ems, 70% with Asp, and 71% overall. A second fundoplication was required for 15 children (16%) because of documented recurrent reflux. The type of GF, the age of the patient, and the presence of EA or NI did not significantly affect the success of GF.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1994        PMID: 8035282     DOI: 10.1016/0022-3468(94)90739-0

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  9 in total

1.  Trends in gastrostomy tube placement with concomitant Nissen fundoplication for infants and young children at Pediatric Tertiary Centers.

Authors:  Megan E Bouchard; Danielle Howard Stewart; Matt Hall; Benjamin T Many; Jonathan C Vacek; Steven Papastefan; Kyle Van Arendonk; Fizan Abdullah; Seth D Goldstein
Journal:  Pediatr Surg Int       Date:  2021-01-24       Impact factor: 1.827

Review 2.  Optimizing the Use of Medications and Other Therapies in Infant Gastroesophageal Reflux.

Authors:  Steven L Ciciora; Frederick W Woodley
Journal:  Paediatr Drugs       Date:  2018-12       Impact factor: 3.022

3.  Evolution of the modified Rossetti fundoplication in children: surgical technique and results.

Authors:  M S Levy; C W Sorrels; C W Wagner; R J Jackson; R W Barnes; S D Smith
Journal:  Ann Surg       Date:  1999-06       Impact factor: 12.969

4.  Postfundoplication Complications in Children.

Authors:  Susan R. Orenstein; Carlo Di Lorenzo
Journal:  Curr Treat Options Gastroenterol       Date:  2001-10

5.  Reoperation after Nissen fundoplication in children with gastroesophageal reflux: experience with 130 patients.

Authors:  L K Dalla Vecchia; J L Grosfeld; K W West; F J Rescorla; L R Scherer; S A Engum
Journal:  Ann Surg       Date:  1997-09       Impact factor: 12.969

Review 6.  Complete versus partial fundoplication in children with gastroesophageal reflux disease: results of a systematic review and meta-analysis.

Authors:  F A Mauritz; B A Blomberg; R K Stellato; D C van der Zee; P D Siersema; M Y A van Herwaarden-Lindeboom
Journal:  J Gastrointest Surg       Date:  2013-08-14       Impact factor: 3.452

7.  Gastroesophageal reflux in children with neurological impairment: a systematic review and meta-analysis.

Authors:  Giuseppe Lauriti; Gabriele Lisi; Pierluigi Lelli Chiesa; Augusto Zani; Agostino Pierro
Journal:  Pediatr Surg Int       Date:  2018-08-13       Impact factor: 1.827

8.  Fundoplication in neonates and infants with primary gastroesophageal reflux.

Authors:  Byung Geon Yoo; Hea Kyoung Yang; Yeoun Joo Lee; Shin Yun Byun; Hae Young Kim; Jae Hong Park
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2014-06-30

Review 9.  Partial versus complete fundoplication for the correction of pediatric GERD: a systematic review and meta-analysis.

Authors:  Peter Glen; Michaël Chassé; Mary-Anne Doyle; Ahmed Nasr; Dean A Fergusson
Journal:  PLoS One       Date:  2014-11-11       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.